On June 11, Baird downgraded UnitedHealth Group Incorporated (NYSE:UNH) to Neutral from Outperform, bringing the price target to $312 from $356.

Fintel reports that on June 11, 2025, Baird downgraded their outlook for UnitedHealth Group (NYSE:UNH) from Outperform to Neutral. Analyst Price Forecast Suggests 32.56% Upside As of June 2, 2025 ...

UnitedHealth Group's string of bad news goes back to early 2024. Many of the issues the healthcare giant faces should be only temporary. The stock's low valuation could present an opportunity for ...

UnitedHealth Group (NYSE: UNH) is all those things. Shares of UnitedHealth Group have plunged more than 50% below the peak achieved late last year. Problems have hit the world's largest health ...

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make it a compelling buy-and-hold. Read more here.

UnitedHealth Group shares appear undervalued after 50% decline, and concerns about a potential DOJ investigation seem overblown. Click to read why UNH is a Buy.

UnitedHealth Group (NYSE: UNH) will release its second quarter 2025 financial results on Tuesday, July 29, 2025, before the market opens, and will host a teleconference at 8:45 a.m. ET to discuss ...

Analysis: The No Good, Very Bad Year for UnitedHealth UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up and mounting regulatory scrutiny.

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- On May 15, 2025, investors in UnitedHealth Group (NYSE: UNH) saw the price of their shares crater as much as $59.13 (-19%) after The Wall Street ...

Two lawsuits accused UnitedHealth Group and its 401 (k) plan fiduciaries of violating ERISA by misusing employer matching funds forfeited by employees who left the company before being full vested.